-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Talis Biomedical Corp annual/quarterly Depreciation history and growth rate for Q3 2022.
- Talis Biomedical Corp Depreciation for the quarter ending September 30, 2022 was $3.3M.
- Talis Biomedical Corp annual Depreciation for 2022 was $6.6M, a 313% increase from 2021.
- Talis Biomedical Corp annual Depreciation for 2021 was $1.6M, a 100% increase from 2020.